Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04610489 · ClinicalTrials.gov registry record · NA
Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19)
A NA study, sponsored by Carilion Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 117
- Enrollment target
NCT04610489: Clinical Trial NA study, sponsored by Carilion Clinic.
NCT04610489 is a NA study that was terminated before completion, run by Carilion Clinic. The registered enrollment target is 117 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04610489, a NA study, was terminated before completion, sponsored by Carilion Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
Study Summary
A comparison of a direct antigen test for SARS-CoV-2 obtained by mid-turbinate swab with the reference standard rt-PCR test obtained by nasopharyngeal swab in outpatients with symptoms compatible with COVID-19.
Primary Outcome
Of all Disease (rtPCR) Positive subjects, the proportion who were Test (antigen) Positive (sensitivity).
Interventions
- DIAGNOSTIC_TEST Quidel Sofia SARS Antigen FIA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2020-11-13 |
| Est. Completion | 2021-03-10 |
| Phase | NA |
Why NCT04610489 stopped before completion
NCT04610489 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Quidel Sofia SARS Antigen FIA is the first listed.
NCT04610489 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04610489 about?
NCT04610489 is a clinical study titled "Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19)". A comparison of a direct antigen test for SARS-CoV-2 obtained by mid-turbinate swab with the reference standard rt-PCR test obtained by nasopharyngeal swab in outpatients with symptoms compatible with COVID-19.
What is the current status of trial NCT04610489?
This trial is currently terminated. It is a NA study. The enrollment target is 117 participants. The study started on 2020-11-13. Estimated completion is 2021-03-10.
What interventions are being tested in trial NCT04610489?
The interventions under investigation include: Quidel Sofia SARS Antigen FIA (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04610489?
This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04610489's enrollment target sits among peer trials
117 807th of 2000 higher than 1,193 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI